ArticleInflammatory bowel diseases2018

Genetic Markers Predict Primary Nonresponse and Durable Response to Anti-Tumor Necrosis Factor Therapy in Ulcerative Colitis.

Kristin E Burke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.